Filed: 2/13/2024ACC: 0001999371-24-002152
📋 What this filing means
AFFINITY ASSET ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 76 equity positions with a total reported market value of $547.53M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
76
Positions
$547.53M
Total AUM (reported)
61.72M
Total Shares
Allocation by class
COM$321.99M58.8%
SPONSORED ADS$77.78M14.2%
COM NEW$54.80M10.0%
NOTE 2.500% 3/1$20.58M3.8%
SHS$20.04M3.7%
COMMON STOCK$18.87M3.4%
SPON ADS$9.98M1.8%
Portfolio Concentration
Top 3$107.90M19.7%
4–10$145.69M26.6%
11–25$169.03M30.9%
Rest$124.91M22.8%
Top 3 weight
19.7%
Top 10 weight
46.3%
Voting Authority Distribution
Total shares with voting rights: 61.72M
Sole
Full voting authority
61.72M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole76
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings76
Rows:
IMMUNOGEN INC
SOLEShares1.40M
TypeSH
Market value$41.65M
7.61%
Sole
1.40M
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares3.30M
TypeSH
Market value$34.45M
6.29%
Sole
3.30M
Shared
0.00
None
0.00
CEREVEL THERAPEUTICS HLDNG I
SOLEShares750K
TypeSH
Market value$31.80M
5.81%
Sole
750K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares1.09M
TypeSH
Market value$25.76M
4.70%
Sole
1.09M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares100K
TypeSH
Market value$23.14M
4.23%
Sole
100K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares460K
TypeSH
Market value$21.19M
3.87%
Sole
460K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares17M
TypePRN
Market value$20.58M
3.76%
Sole
17M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares541.39K
TypeSH
Market value$19.26M
3.52%
Sole
541.39K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares340K
TypeSH
Market value$18.87M
3.45%
Sole
340K
Shared
0.00
None
0.00
LIANBIO
SOLEShares3.78M
TypeSH
Market value$16.90M
3.09%
Sole
3.78M
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares400K
TypeSH
Market value$15.86M
2.90%
Sole
400K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares537.09K
TypeSH
Market value$15.01M
2.74%
Sole
537.09K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares345K
TypeSH
Market value$14.53M
2.65%
Sole
345K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares160K
TypeSH
Market value$13.36M
2.44%
Sole
160K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares175K
TypeSH
Market value$12.88M
2.35%
Sole
175K
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares453.28K
TypeSH
Market value$11.74M
2.14%
Sole
453.28K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares1.47M
TypeSH
Market value$11.26M
2.06%
Sole
1.47M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares563.82K
TypeSH
Market value$11.21M
2.05%
Sole
563.82K
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares517.55K
TypeSH
Market value$11.14M
2.03%
Sole
517.55K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares383.38K
TypeSH
Market value$10.64M
1.94%
Sole
383.38K
Shared
0.00
None
0.00
AUTOLUS THERAPEUTICS PLC
SOLEShares1.55M
TypeSH
Market value$9.98M
1.82%
Sole
1.55M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares430K
TypeSH
Market value$9.94M
1.81%
Sole
430K
Shared
0.00
None
0.00
INOZYME PHARMA INC
SOLEShares1.89M
TypeSH
Market value$8.03M
1.47%
Sole
1.89M
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares690.11K
TypeSH
Market value$7.12M
1.30%
Sole
690.11K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares795.73K
TypeSH
Market value$6.33M
1.16%
Sole
795.73K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
IMMUNOGEN INCSOLE | COM | 1.40M | SH | $41.65M 7.61% | 1.40M | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 3.30M | SH | $34.45M 6.29% | 3.30M | 0.00 | 0.00 |
CEREVEL THERAPEUTICS HLDNG ISOLE | COM | 750K | SH | $31.80M 5.81% | 750K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 1.09M | SH | $25.76M 4.70% | 1.09M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 100K | SH | $23.14M 4.23% | 100K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 460K | SH | $21.19M 3.87% | 460K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.500% 3/1 | 17M | PRN | $20.58M 3.76% | 17M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 541.39K | SH | $19.26M 3.52% | 541.39K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 340K | SH | $18.87M 3.45% | 340K | 0.00 | 0.00 |
LIANBIOSOLE | SPONSORED ADS | 3.78M | SH | $16.90M 3.09% | 3.78M | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 400K | SH | $15.86M 2.90% | 400K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 537.09K | SH | $15.01M 2.74% | 537.09K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 345K | SH | $14.53M 2.65% | 345K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 160K | SH | $13.36M 2.44% | 160K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 175K | SH | $12.88M 2.35% | 175K | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 453.28K | SH | $11.74M 2.14% | 453.28K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 1.47M | SH | $11.26M 2.06% | 1.47M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 563.82K | SH | $11.21M 2.05% | 563.82K | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 517.55K | SH | $11.14M 2.03% | 517.55K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 383.38K | SH | $10.64M 1.94% | 383.38K | 0.00 | 0.00 |
AUTOLUS THERAPEUTICS PLCSOLE | SPON ADS | 1.55M | SH | $9.98M 1.82% | 1.55M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 430K | SH | $9.94M 1.81% | 430K | 0.00 | 0.00 |
INOZYME PHARMA INCSOLE | COM | 1.89M | SH | $8.03M 1.47% | 1.89M | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 690.11K | SH | $7.12M 1.30% | 690.11K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 795.73K | SH | $6.33M 1.16% | 795.73K | 0.00 | 0.00 |
Page 1 of 4